| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin
|
Grosso, Federica
|
|
2012
|
69 |
6 |
p. 1557-1565
|
article
|
| 2 |
9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma
|
Teitelbaum, Aaron M.
|
|
2012
|
69 |
6 |
p. 1519-1527
|
article
|
| 3 |
An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors
|
Asahina, Hajime
|
|
2012
|
69 |
6 |
p. 1477-1486
|
article
|
| 4 |
An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel
|
Uchiyama, Toshitaka
|
|
2012
|
69 |
6 |
p. 1617-1624
|
article
|
| 5 |
A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)
|
Hida, Naoya
|
|
2012
|
69 |
6 |
p. 1625-1631
|
article
|
| 6 |
Ascorbic acid and healthy lymphocytes: a way to explain anticancer activity?
|
Rodemeister, Sandra
|
|
2012
|
69 |
6 |
p. 1673-1674
|
article
|
| 7 |
A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults
|
Boni, Joseph P.
|
|
2012
|
69 |
6 |
p. 1433-1442
|
article
|
| 8 |
Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study
|
Jansen, Robert S.
|
|
2012
|
69 |
6 |
p. 1457-1466
|
article
|
| 9 |
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model
|
Mudd, Sarah R.
|
|
2012
|
69 |
6 |
p. 1669-1672
|
article
|
| 10 |
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
|
Zaniboni, Alberto
|
|
2012
|
69 |
6 |
p. 1641-1645
|
article
|
| 11 |
Lenalidomide in solid tumors
|
Segler, Angela
|
|
2012
|
69 |
6 |
p. 1393-1406
|
article
|
| 12 |
Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: evidence from retrospective studies
|
Wang, Zhen-Hua
|
|
2012
|
69 |
6 |
p. 1647-1655
|
article
|
| 13 |
Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
|
Emi, Manabu
|
|
2012
|
69 |
6 |
p. 1499-1505
|
article
|
| 14 |
Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions
|
Xia, Binfeng
|
|
2012
|
69 |
6 |
p. 1567-1582
|
article
|
| 15 |
Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men
|
Acharya, M.
|
|
2012
|
69 |
6 |
p. 1583-1590
|
article
|
| 16 |
Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors
|
Calvo, E.
|
|
2012
|
69 |
6 |
p. 1467-1475
|
article
|
| 17 |
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
|
Reardon, David A.
|
|
2012
|
69 |
6 |
p. 1507-1518
|
article
|
| 18 |
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
|
Reardon, David A.
|
|
|
69 |
6 |
p. 1507-1518
|
article
|
| 19 |
Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas
|
Dong, Mei
|
|
2012
|
69 |
6 |
p. 1413-1422
|
article
|
| 20 |
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer
|
Asakuma, Maiko
|
|
2012
|
69 |
6 |
p. 1529-1536
|
article
|
| 21 |
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
|
Bose, Prithviraj
|
|
2012
|
69 |
6 |
p. 1657-1667
|
article
|
| 22 |
Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity
|
Al Safarjalani, Omar N.
|
|
2012
|
69 |
6 |
p. 1449-1455
|
article
|
| 23 |
Preclinical pharmacology of novel indolecarboxamide ML-970, an investigative anticancer agent
|
Rayburn, Elizabeth
|
|
2012
|
69 |
6 |
p. 1423-1431
|
article
|
| 24 |
Reply
|
Hadi, S. M.
|
|
2012
|
69 |
6 |
p. 1675
|
article
|
| 25 |
RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1α and inhibition phosphorylation of AKT and mTOR
|
Liu, Ziwei
|
|
2012
|
69 |
6 |
p. 1633-1640
|
article
|
| 26 |
Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines
|
Mueller, Annett
|
|
2012
|
69 |
6 |
p. 1601-1615
|
article
|
| 27 |
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules
|
Liu, Qian
|
|
2012
|
69 |
6 |
p. 1487-1498
|
article
|
| 28 |
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
|
Grossi, Francesco
|
|
2012
|
69 |
6 |
p. 1407-1412
|
article
|
| 29 |
The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells
|
Takeba, Yuko
|
|
2012
|
69 |
6 |
p. 1545-1555
|
article
|
| 30 |
The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum
|
Xie, Fa-Jun
|
|
2012
|
69 |
6 |
p. 1443-1448
|
article
|
| 31 |
The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens
|
Lamas, M. J.
|
|
2012
|
69 |
6 |
p. 1591-1599
|
article
|
| 32 |
Transient elevation of serum cystatin C concentrations during perioperative cisplatin-based chemotherapy in esophageal cancer patients
|
Kume, Manabu
|
|
2012
|
69 |
6 |
p. 1537-1544
|
article
|
Journal description